The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Gastric Inhibitory Polypeptide as an Endogenous Factor Promoting New Bone Formation after Food Ingestion
Open accessAbstract
Calcium plays a fundamental role as second messenger in intracellular signaling and bone serves as the body’s calcium reserve to tightly maintain blood calcium levels. Calcium in ingested meal is the main supply and inadequate calcium intake causes osteoporosis and bone fracture. Here, we describe a novel mechanism of how ingested calcium is deposited on bone. Meal ingestion elicits secretion of the gut hormone gastric inhibitory polypeptide (GIP) from endocrine K cells in the duodenum. Bone histomorphometrical analyses revealed that bone formation parameters in the mice lacking GIP receptor (GIPR−/−) were significantly lower than those of wild-type (GIPR+/+) mice, and that the number of osteoclasts, especially multinuclear osteoclasts, was significantly increased in GIPR−/− mice, indicating that GIPR−/− mice have high-turnover osteoporosis. In vitro examination showed the percentage of osteoblastic cells undergoing apoptosis to be significantly decreased in the presence of GIP. Because GIPR−/− mice exhibited an increased plasma calcium concentration after meal ingestion, GIP directly links calcium contained in meal to calcium deposition on bone.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“GIP also stimulates bone formation by inhibiting osteoclast apoptosis [52].”
From New Developments in Pharmacological Treatment of Obesity and Type 2 Diabetes—Beyond and within GLP-1 Receptor Agonists (2024) · cites this paper as [52]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“These findings suggest that liraglutide specifically reduces bone resorption without influencing bone formation.368”
From Glucagon-like peptide-1 receptor: mechanisms and advances in therapy (2024) · cites this paper as [368]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PARFITT, A. M., Drezner, M. K., Glorieux, F. H., Kanis, J. А., Malluche, H. H., Meunier, P. J., Ott, S. M., & Recker, R. R. (1987) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650020617 · Cited by 5,344
Neer, R. M., Arnaud, C. D., Zanchetta, J. R., Prince, R., Gaich, G. A., Reginster, J.-Y., Hodsman, A. B., Eriksen, E. F., Ish-Shalom, S., Genant, H. K., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105103441904 · Cited by 4,602
Suda, T., Takahashi, N., Udagawa, N., Jimi, E., Gillespie, M. T., & Martin, T. J. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.3.0367 · Cited by 2,345
Self-citationDawson‐Hughes, B., Harris, S. S., Krall, E. A., & Dallal, G. E. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709043371003 · Cited by 2,276
Lips, P. (2001) · Endocrine reviews · doi:10.1210/edrv.22.4.0437 · Cited by 2,203
Genetic regulation of osteoclast development and function
Teitelbaum, S. L., & Ross, F. P. (2003) · Nature Reviews Genetics · doi:10.1038/nrg1122 · Cited by 1,720
The Osteoblast: A Sophisticated Fibroblast under Central Surveillance
Ducy, P. F., Schinke, T., & Karsenty, G. (2000) · Science · doi:10.1126/science.289.5484.1501 · Cited by 1,137
Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone
Jilka, R. L., Weinstein, R. S., Bellido, T., Roberson, P. K., PARFITT, A. M., & Manolagas, S. C. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6610 · Cited by 1,042
Inhibition of gastric inhibitory polypeptide signaling prevents obesity
Miyawaki, K., Yamada, Y., Ban, N., Ihara, Y., Tsukiyama, K., Zhou, H., Fujimoto, S., Oku, A., Tsuda, K., Toyokuni, S., et al. (2002) · Nature Medicine · doi:10.1038/nm727 · Cited by 963
Self-citationA Controlled Trial of the Effect of Calcium Supplementation on Bone Density in Postmenopausal Women
Dawson‐Hughes, B., Dallal, G. E., Krall, E. A., Sadowski, L., Sahyoun, N. R., & Tannenbaum, S. (1990) · New England Journal of Medicine · doi:10.1056/nejm199009273231305 · Cited by 945
Cited by
Sorted by citations
Items 101–196 of 196
Mechanisms of action of incretin receptor based dual- and tri-agonists in pancreatic islets
Folli, F. B., Finzi, G., Manfrini, R., Galli, A., Casiraghi, F., Centofanti, L., Berra, C., Fiorina, P., Davalli, A. M., Rosa, S. L., et al. (2023) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00236.2023 · Cited by 32
Paschetta, E., Hvalryg, M., & Musso, G. (2011) · Obesity Reviews · doi:10.1111/j.1467-789x.2011.00897.x · Cited by 34
Alliances of the gut and bone axis
Hansen, M. S., & Frost, M. (2021) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2021.06.024 · Cited by 32
GIP analogues augment bone strength by modulating bone composition in diet-induced obesity in mice
Vyavahare, S. S., Mieczkowska, A., Flatt, P. R., Chappard, D., Irwin, N., & Mabilleau, G. (2019) · Peptides · doi:10.1016/j.peptides.2019.170207 · Cited by 30
Liu, H., Xiao, H., Lin, S., Zhou, H., Cheng, Y., Xie, B., & Xu, D. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1372399 · Cited by 35
Li, Y., Li, L., & Hölscher, C. (2016) · Reviews in the Neurosciences · doi:10.1515/revneuro-2016-0018 · Cited by 28
Gobron, B., Couchot, M., Irwin, N., Legrand, É., Bouvard, B., & Mabilleau, G. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.4792 · Cited by 29
Miyachi, A., Murase, T., Yamada, Y., Osonoi, T., & Harada, K. (2013) · Journal of Proteome Research · doi:10.1021/pr400069f · Cited by 27
Self-citationIncretins and bone: Evolving concepts in nutrient-dependent regulation of bone turnover
Yavropoulou, M. P., & Yovos, J. G. (2013) · HORMONES · doi:10.14310/horm.2002.1405 · Cited by 28
Mantelmacher, F. D., Fishman, S., Cohen, K., Pasmanik Chor, M., Yamada, Y., Zvibel, I., & Varol, C. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601441 · Cited by 27
Self-citationIntestinal Incretins and the Regulation of Bone Physiology
Ramsey, W. A., & Isales, C. M. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-66653-2_2 · Cited by 27
Guccio, N., Gribble, F. M., & Reimann, F. M. (2022) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-062320-113625 · Cited by 30
Gut hormones and bone homeostasis: potential therapeutic implications
Bouvard, B., & Mabilleau, G. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-024-01000-z · Cited by 26
Berlier, J. L., Kharroubi, I., Zhang, J., Valle, A. D., Rigutto, S., Mathieu, M., Gangji, V., & Rasschaert, J. (2015) · Stem Cell Reviews and Reports · doi:10.1007/s12015-015-9616-6 · Cited by 26
Anti‐inflammatory role of glucose‐dependent insulinotropic polypeptide in periodontitis
Suzuki, Y., Nakamura, N., Miyabe, M., Nishikawa, T., Miyajima, S., Adachi, K., Mizutani, M., Kikuchi, T., Miyazawa, K., Goto, S., et al. (2015) · Journal of Diabetes Investigation · doi:10.1111/jdi.12450 · Cited by 26
Self-citationVianna, A. G. D., de Lacerda, C. S., Pechmann, L. M., Polesel, M. G., Marino, E. C., Borba, V. Z. C., & Barreto, F. D. C. (2017) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-017-0232-2 · Cited by 25
Anastasiou, I. A., Argyrakopoulou, G., Dalamaga, Μ., & Kokkinos, A. D. (2025) · Current Obesity Reports · doi:10.1007/s13679-025-00623-1 · Cited by 28
The Effect of Type 2 Diabetes on Bone Biomechanics
Karim, L., Rezaee, T., & Vaidya, R. (2019) · Current Osteoporosis Reports · doi:10.1007/s11914-019-00526-w · Cited by 24
Pharmacological Actions of Glucagon-Like Peptide-1, Gastric Inhibitory Polypeptide, and Glucagon
Sekar, R., Singh, K., Arokiaraj, A. W. R., & Chow, B. (2016) · International review of cytology · doi:10.1016/bs.ircmb.2016.05.002 · Cited by 26
Efficacy of targeting bone-specific GIP receptor in ovariectomy-induced bone loss
Mabilleau, G., Gobron, B., Mieczkowska, A., Perrot, R., & Chappard, D. (2018) · Journal of Endocrinology · doi:10.1530/joe-18-0214 · Cited by 22
Kanda, J., Furukawa, M., Izumo, N., Shimakura, T., Yamamoto, N., Takahashi, H. E., & Wakabayashi, H. (2020) · Drug Discoveries & Therapeutics · doi:10.5582/ddt.2020.03073 · Cited by 21
Lanthanum salts improve bone formation in a small animal model of post‐menopausal osteoporosis
von Rosenberg, S. J., & Wehr, U. (2012) · Journal of Animal Physiology and Animal Nutrition · doi:10.1111/j.1439-0396.2012.01326.x · Cited by 21
Trautvetter, U., & Jahreis, G. (2013) · British Journal Of Nutrition · doi:10.1017/s0007114513002341 · Cited by 21
Incretin-based therapy for the treatment of bone fragility in diabetes mellitus
Mabilleau, G., Gobron, B., Bouvard, B., & Chappard, D. (2018) · Peptides · doi:10.1016/j.peptides.2017.12.008 · Cited by 19
Okawa, T., Kamiya, H., Himeno, T., Seino, Y., Tsunekawa, S., Hayashi, Y., Harada, N., Yamada, Y., Inagaki, N., Seino, Y., et al. (2013) · Journal of Diabetes Investigation · doi:10.1111/jdi.12129 · Cited by 17
Self-citationSuvan, J. E., Masi, S., Harrington, Z., Santini, E., Raggi, F., D’Aiuto, F., & Solini, A. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa757 · Cited by 17
Enteroendocrine K Cells Exert Complementary Effects to Control Bone Quality and Mass in Mice
Gobron, B., Bouvard, B., Vyavahare, S. S., Christensen, L. V. V., Pedersen, K. K., Windeløv, J. A., Boer, G. A., Harada, N., Zhang, S., Shimazu‐Kuwahara, S., et al. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.4004 · Cited by 17
Self-citationInfluence of Hormonal Appetite and Energy Regulators on Bone
Khor, E. C., Wee, N. K. Y., & Baldock, P. A. J. (2013) · Current Osteoporosis Reports · doi:10.1007/s11914-013-0157-0 · Cited by 17
GIP-Based Therapeutics for Diabetes and Obesity
Gault, V. A., Irwin, N., & Flatt, P. R. (2008) · Current Chemical Biology · doi:10.2174/187231308783334108 · Cited by 17
Reed, J., Bain, S. C., & Kanamarlapudi, V. (2024) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s415934 · Cited by 21
Daley, E. J., Pajevic, P. D., Roy, S., & Trackman, P. C. (2019) · JBMR Plus · doi:10.1002/jbm4.10212 · Cited by 16
Physiology and clinical applications of GIP
Yamane, S., Harada, N., & Inagaki, N. (2025) · Endocrine Journal · doi:10.1507/endocrj.ej25-0087 · Cited by 15
Self-citationThe effects of anti‐obesity medications on bone metabolism: A critical appraisal
Anastasilakis, A. D., Paccou, J., Palermo, A., & Pοlyzos, S. A. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16541 · Cited by 18
Interplay between bone and incretin hormones: A review
Mabilleau, G. (2016) · Morphologie · doi:10.1016/j.morpho.2016.06.004 · Cited by 16
Liu, X., Harada, N., Yamane, S., Kitajima, L., Uchida, S., Hamasaki, A., Mukai, E., Toyoda, K., Yamada, C., Yamada, Y., et al. (2009) · Life Sciences · doi:10.1016/j.lfs.2009.03.022 · Cited by 15
Self-citationEvolutionary expression of glucose-dependent-insulinotropic polypeptide (GIP)
Musson, M. C., Jepeal, L. I., Finnerty, J. R., & Wolfe, M. M. (2011) · Regulatory Peptides · doi:10.1016/j.regpep.2011.06.001 · Cited by 14
Garg, G., McGuigan, F. E., Kumar, J., Luthman, H., Lyssenko, V., & Åkesson, K. (2015) · Bone Reports · doi:10.1016/j.bonr.2015.12.001 · Cited by 13
Incretins and bone: friend or foe?
Mabilleau, G. (2015) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2015.03.007 · Cited by 13
Notsu, M., Kanazawa, I., Tanaka, S., Yamaguchi, T., & Sugimoto, T. (2015) · Clinical Endocrinology · doi:10.1111/cen.12971 · Cited by 12
Lima, T. P., Nicoletti, C. F., Marchini, J. S., Salgado, W., & Nonino, C. B. (2014) · Journal of Clinical Densitometry · doi:10.1016/j.jocd.2014.08.002 · Cited by 11
Matsuo, T., Kusunoki, Y., Katsuno, T., Ikawa, T., Akagami, T., Murai, K., Miuchi, M., Miyagawa, J., & Namba, M. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.09.002 · Cited by 10
The bone-fat mass relationship: Laboratory studies
Cornish, J., Costa, J. L., & Naot, D. (2009) · IBMS BoneKEy · doi:10.1138/20090395 · Cited by 10
Food Intake Affects Sperm-Egg Fusion Through the GIP/PSG17 Axis in Mice
Shimizu, T., Sato, T. K., Tsukiyama, K., Fujita, H., Kato, S., Hoizumi, M., Shirasawa, H., Narita, T., Terada, Y., Seino, Y., et al. (2017) · Endocrinology · doi:10.1210/en.2016-1861 · Cited by 11
Self-citationIncretins today: multiple effects and therapeutic potential
Васильевна, Ц. О., Васильевна, В. В., & As, A. (2019) · Diabetes Mellitus · doi:10.14341/dm9841 · Cited by 11
Sphingosine kinase 1–interacting protein is a dual regulator of insulin and incretin secretion
Liu, Y., Harashima, S., Wang, Y., Suzuki, K., Tokumoto, S., Usui, R., Tatsuoka, H., Tanaka, D., Yabe, D., Harada, N., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201801783rr · Cited by 10
Self-citationLin, A., Kitaura, H., Ohori, F., Noguchi, T., Marahleh, A., Ma, J., Ren, J., Miura, M., Fan, Z., Narita, K., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052555 · Cited by 9
Energy Balance, Myostatin, and GILZ: Factors Regulating Adipocyte Differentiation in Belly and Bone
Shi, X., Hamrick, M. W., & Isales, C. M. (2007) · PPAR Research · doi:10.1155/2007/92501 · Cited by 9
Shimazu‐Kuwahara, S., Kanemaru, Y., Harada, N., Ikeguchi, E., Ueda, Y., Yamane, S., Murata, Y., Yasoda, A., Kieffer, T. J., & Inagaki, N. (2018) · Journal of Diabetes Investigation · doi:10.1111/jdi.12978 · Cited by 8
Self-citationPathogenesis of type 2 diabetes in Japan and East Asian populations: Basic and clinical explorations
Seino, Y., & Yamazaki, Y. (2025) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.101.009 · Cited by 9
Self-citationDaley, E. J., & Trackman, P. C. (2021) · Bone Reports · doi:10.1016/j.bonr.2021.101063 · Cited by 8
Nutritional control of thyroid morphogenesis through gastrointestinal hormones
Takagishi, M., Aleogho, B. M., Okumura, M., Ushida, K., Yamada, Y., Seino, Y., Fujimura, S., Nakashima, K., & Shindo, A. (2022) · Current Biology · doi:10.1016/j.cub.2022.01.075 · Cited by 8
Self-citationPrivatananupunt, J., Watari, I., Podyma‐Inoue, K. A., Mizumachi-Kubono, M., & Ono, T. (2013) · Acta Histochemica · doi:10.1016/j.acthis.2013.11.007 · Cited by 7
The hunger games of skeletal metabolism
Wee, N. K. Y., & Baldock, P. A. J. (2014) · BoneKEy Reports · doi:10.1038/bonekey.2014.83 · Cited by 7
Molecular genetic studies of gene identification for osteoporosis
Guo, Y., Yang, T., Pan, F., Xu, X., Dong, S., & Deng, H. (2008) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.3.2.223 · Cited by 7
Hanna, A., Connelly, K. A., Josse, R. G., & McIntyre, R. S. (2014) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2015.972370 · Cited by 6
GLP-1 and GIP: Magic bullet for musculoskeletal diseases?
Fang, Q., Gan, L., Liu, P., Ding, P., & Gao, Y. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.08.046 · Cited by 5
Pharmacological Risk Assessment for Dental Implants
Wu, X., & Tamimi, F. (2018) · Springer eBooks · doi:10.1007/978-3-319-71181-2_4 · Cited by 5
Yamauchi, T., Miyabe, M., Nakamura, N., Ito, M., Sekiya, T., Kanada, S., Hoshino, R., Matsubara, T., Miyazawa, K., Goto, S., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23168922 · Cited by 5
Lei, W. S., Kilberg, M. J., Zemel, B. S., Rubenstein, R. C., Harris, C., Sheikh, S., Kelly, A. T., & Kindler, J. M. (2022) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2022.100304 · Cited by 5
GIPR rs10423928 and bone mineral density in postmenopausal women in Shanghai
Zhang, L., He, J., Sun, X., Pang, D., Hu, J., & Feng, B. (2022) · Endocrine Connections · doi:10.1530/ec-21-0583 · Cited by 4
Hyperglycaemia induced osteoporosis: Is there a hope with dipeptidyl peptidase-4 inhibitors?
Ahmed, F., Ahmad, S. S., Alam, M. M., Khatoon, A., Ali, R., Ahmad, J., Amina, N., Najmi, A. K., & Khan, M. A. (2023) · Health Sciences Review · doi:10.1016/j.hsr.2023.100135 · Cited by 4
Li, X., & Petrov, M. S. (2024) · Nutrients · doi:10.3390/nu16030435 · Cited by 7
Diabetes and fatty liver: Involvement of incretin and its benefit for fatty liver management
Wibawa, I. D. N., Mariadi, I. K., Somayana, G., Kumbara, C. I. Y. K., & Sindhughosa, D. A. (2023) · World Journal of Diabetes · doi:10.4239/wjd.v14.i5.549 · Cited by 3
Elevated fasting and postprandial C-terminal telopeptide after Roux-en-Y gastric bypass
Maghsoodi, N., Alaghband‐Zadeh, J., Cross, G. F., Werling, M., Fändriks, L., Docherty, N. G., Olbers, T., Dew, T. K., Sherwood, R. A., Vincent, R. P., et al. (2016) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/0004563216667964 · Cited by 3
Emerging incretin hormones actions: focus on bone metabolism
Grammatiki, M., Antonopoulou, V., & Kotsa, K. (2019) · Minerva Endocrinology · doi:10.23736/s0391-1977.19.03008-6 · Cited by 3
Still, C. D., Benotti, P. N., Hangan, D., & Zubair, F. (2018) · Springer eBooks · doi:10.1007/978-3-319-75841-1_2 · Cited by 3
Nirwan, N., Jain, S., & Vohora, D. (2025) · Bone · doi:10.1016/j.bone.2025.117526 · Cited by 3
Almohammad, A. A., Aldossari, S. K., Sukumbaji, Z. A., Faden, R. A., Almutairi, M. A., Al-Harbi, N. H., Al-Saaib, M. Y., Almarshedy, B., Alharabi, E., Alhazri, W. A., et al. (2025) · Cureus · doi:10.7759/cureus.95792 · Cited by 2
The Role of Glucose-Dependent Insulinotropic Polypeptide (GIP) in Bone Metabolism
Lin, A., Kitaura, H., Ohori, F., Marahleh, A., Ma, J., Fan, Z., Narita, K., Murakami, K., & KANETAKA, H. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27020600 · Cited by 2
Seventh Meeting on Bone Quality 2012: Bone–Fat Interactions
AuthorName (2013) · Osteoporosis International · doi:10.1007/s00198-013-2370-1 · Cited by 2
Gorvin, C. M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00020-7 · Cited by 2
(2018) · Springer eBooks · doi:10.1007/978-3-319-71181-2 · Cited by 2
Effects of Feeding on Bone Metabolism
Walsh, J., & Eastell, R. (2009) · Clinical Reviews in Bone and Mineral Metabolism · doi:10.1007/s12018-009-9052-8 · Cited by 2
Bariatric Surgery, Vitamin D, and Bone Loss
Tiffany Y, K., & Schafer, A. L. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809963-6.00064-x · Cited by 2
Diabetes, diabetic medications, and risk of fracture
D’Onofrio, L., Palermo, A., & Napoli, N. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813073-5.00050-2 · Cited by 1
Clinical Potential of GIP in Type 2 Diabetes and Obesity
Nauck, M. A., Gribble, F. M., Reimann, F. M., D’Alessio, D. A., & Campbell, J. E. (2026) · Diabetes Care · doi:10.2337/dci25-0141 · Cited by 1
Ostéoporose induite par les antidiabétiques
Lafage‐Proust, M. (2011) · Revue du Rhumatisme Monographies · doi:10.1016/j.monrhu.2011.02.001 · Cited by 1
Gastric inhibitory polypeptide receptor
Hoersch, D., & Schrader, J. (2007) · AfCS-Nature Molecule Pages · doi:10.1038/mp.a001028.01 · Cited by 1
Саприна, Т. В., Timokhina, Y. S., Мусина, Н. Н., Prokhorenko, T. S., Таширева, Л. А., & Goncharevich, O. K. (2013) · Bulletin of Siberian Medicine · doi:10.20538/1682-0363-2013-3-132-147 · Cited by 1
Koh, G. (2014) · The Korean Journal of Obesity · doi:10.7570/kjo.2014.23.1.6 · Cited by 1
Obesity Insulin Resistance and Gut Hormones
Proietto, J. (2009) · Wiley eBooks · doi:10.1002/9781444307627.ch14
GASTRIC INHIBITORY POLYPEPTIDE IN THE BRAIN
Nyberg, J. (2009) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Shi, X., Hamrick, M. W., & Isales, C. M. (2007)
Widenmaier, S. B. (2010) · cIRcle (University of British Columbia) · doi:10.14288/1.0071070
Extrapancreatic actions of incretin-based therapies on bone in diabetes mellitus
Mansur, S. A. (2015) · UTHM Institutional Repository (Universiti Tun Hussein Onn Malaysia)
Yamamoto, M., & Sugimoto, T. (2016) · Springer eBooks · doi:10.1007/978-4-431-55720-3_3
Merchant, C. E. (2011) · cIRcle (University of British Columbia) · doi:10.14288/1.0105089
Okada, Y., Mori, H., & Tanaka, Y. (2013) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.102.907
RISK FACTORS OF LOW-ENERGY FRACTURES IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
NURULLINA, G. M., Илгисовна, А. Г., Krasnoperova, O. V., Alekseeva, M. M., ALEKSANDROVA, O. V., & CHERNOVA, A. V. (2018) · Кубанский научный медицинский вестник · doi:10.25207/1608-6228-2018-25-4-115-123
Clinical and basic research papers – June 2006 selections
Ferrari, S., Seeman, E., & Strewler, G. J. (2006) · BoneKEy-Osteovision · doi:10.1138/20060219
(2007) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e32802e6d87
Bariatric surgery, vitamin D, and bone loss
Kim, T. Y., & Schafer, A. L. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91338-6.00009-4
Hormones intestinales et remodelage osseux
Gobron, B. (2020) · theses.fr (ABES) · doi:10.70675/dce7301cz8d6ez4effz9eebz1548099e70f7
Krogh, L. S. L., Hansen, M. B., Bergmann, N. C., Hansen, C. P., Hartmann, B., Holst, J. J., Knop, F. K., Lund, A., & Gasbjerg, L. S. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70940 · Cited by 1
Papastathopoulou, N. S., Neri, S., Assirelli, E., D’Amuri, A., Greco, S., Ciaffi, J., & Ursini, F. (2026) · Rheumatology Advances in Practice · doi:10.1093/rap/rkag105
Metadata
- Authors
- Tsukiyama, K., Yamada, Y., Yamada, C., Harada, N., Kawasaki, Y., Ogura, M., Bessho, K., Li, M., Amizuka, N., Sato, M., Udagawa, N., Takahashi, N., Tanaka, K., Oiso, Y., & Seino, Y.
- Affiliations
- Nagoya University (JP)
- Departments of Diabetes and Clinical Nutrition (K.Ts., Y.Y., C.Y., N.H., Y.K., M.O., Y.S.), Kyoto 606-8507, Japan;
- Kyoto University (JP)
- Niigata University (JP)
- Department of Biochemistry (M.S., N.U.), Nagano 399-0781, Japan;
- Matsumoto Dental University (JP)
- Kyoto Women's University (JP)
- Kansai Electric Power Hospital (JP)
- Corresponding author
- Yamada, Yuichiro
- ORCID
- Venue
- Molecular Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2006-07-01
- Volume
- 20
- Issue
- 7
- Pages
- 1644-1651
- ISSN
- 0888-8809 (ISSN-L)
- 1944-9917
- OpenAlex
- W2103318165
- Cited by
- 198
- References
- 33
- Citations by year
- 2026: 4 · 2025: 9 · 2024: 7 · 2023: 5 · 2022: 9 · 2021: 6 · 2020: 8 · 2019: 17 · 2018: 15 · 2017: 11 · 2016: 12 · 2015: 15 · 2014: 12 · 2013: 18 · 2012: 6
- FWCI
- 3.80
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Molecular Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ministry of Education, Culture, Sports, Science and Technology
- Japan Society for the Promotion of Science
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Nephrology › Parathyroid Disorders and Treatments
- Keywords
- glucose-dependent insulinotropic polypeptide, GIP receptor, bone formation, calcium homeostasis, meal ingestion, gastrointestinal hormones, K cells, osteoclasts, osteoblast apoptosis, plasma calcium, bone histomorphometry
- MeSH terms
- Animals, Bone Resorption, Calcium, Eating, Gastric Inhibitory Polypeptide, Male, Mice, Transgenic, Models, Biological, Osteoblasts, Osteoclasts, Osteogenesis, Osteoporosis, Tibia, Signal Transduction, Apoptosis Regulatory Proteins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
